Konishi Y, Maruyama H, Mii Y, Miyauchi Y, Yokose Y, Masuhara K
J Natl Cancer Inst. 1982 May;68(5):859-65.
Subcutaneous and bone malignant fibrous histiocytomas (MFH) were induced in high incidence in rats by 4-(hydroxyamino)-quinoline 1-oxide (4-HAQO). Subcutaneous MFH were induced locally by repeated weekly injections of 1 mg 4-HAQO/rat for 4 weeks. Between 16 and 48 weeks after the final treatment, 13/15 (87%) male noninbred Wistar rats developed tumors. The histologic subtypes of these tumors were as follows: 11 fibrous, 1 myxoid, and 1 giant cell. Bone MFH were induced between 18 and 25 weeks by implantation of 4-HAQO (8 mg/rat) into the bone marrow of the tibia in 12/14 (86%) male noninbred Fischer 344 rats. The histologic subtypes of these tumors were as follows: 6 fibrous, 4 myxoid, and 2 giant cell. Morphologically, these MFH appeared similar to human MFH.
4-(羟基氨基)喹啉1-氧化物(4-HAQO)可在大鼠中高发病率地诱发皮下和骨恶性纤维组织细胞瘤(MFH)。皮下MFH通过每周重复给每只大鼠注射1mg 4-HAQO,持续4周来局部诱发。在最后一次治疗后的16至48周之间,15只雄性非近交Wistar大鼠中有13只(87%)发生了肿瘤。这些肿瘤的组织学亚型如下:11例纤维型、1例黏液型和1例巨细胞型。通过将4-HAQO(8mg/大鼠)植入胫骨骨髓,在18至25周之间诱发了骨MFH,14只雄性非近交Fischer 344大鼠中有12只(86%)发生了肿瘤。这些肿瘤的组织学亚型如下:6例纤维型、4例黏液型和2例巨细胞型。形态学上,这些MFH与人类MFH相似。